May 15, 2012 03:50 PM IST | Source: Moneycontrol.com

AstraZeneca Mar '12 sales at Rs 91.79 crore

AstraZeneca Pharma has reported a sales turnover of Rs 91.79 crore and a net loss of Rs 33.00 crore for the quarter ended Mar '12

AstraZeneca Mar '12 sales at Rs 91.79 crore
AstraZeneca Pharma has reported a sales turnover of Rs 91.79 crore and a net loss of Rs 33.00 crore for the quarter ended Mar '12.
For the quarter ended Mar 2011 the sales turnover was Rs 126.68 crore and net profit was Rs 8.35 crore.
Quarterly Results of AstraZeneca Pharma-------- in Rs. Cr. --------
Mar '11Dec '11Mar '12
Sales Turnover126.68153.4891.79
Other Income2.201.502.01
Total Income128.88154.9993.80
Total Expenses110.08131.10140.95
Operating Profit16.6022.38-49.16
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses------
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit18.8023.88-47.15
Interest------
PBDT18.8023.89-47.14
Depreciation1.761.891.81
Depreciation On Revaluation Of Assets------
PBT17.0422.00-48.95
Tax8.697.06-15.95
Net Profit8.3514.94-33.00
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share3.345.97--
Book Value------
Equity5.005.005.00
Reserves------
Face Value2.002.002.00
Source : Dion Global Solutions Limited
Sections
Follow us on
Available On